Doximity Q1 profit halves as AI spending surges; $91.6M buyback executed
DOCS sits 27% above its 52-week low of $17.15 on elevated volume (3.8× avg).
Summary
Doximity's Q1 FY2027 net income fell 54% to $24.3M as AI spending surged, but revenue grew 7% to $156.6M. The company bought back $91.6M in stock and settled its securities lawsuit.
Key Events · Earnings and Guidance · DOCS
-
Net Income Halves on AI Spend
Net income fell 54% YoY to $24.3M as operating expenses jumped 31% to $99.3M, driven by a $11.7M increase in R&D and $8.7M in sales and marketing, largely tied to AI initiatives.
-
Revenue Up 7%, Margins Compress
Revenue reached $156.6M, up 7% YoY, but gross margin declined to 85% from 89% due to higher hosting and software costs for AI. Adjusted EBITDA margin fell to 48% from 55%.
-
$91.6M Buyback Executed
Doximity repurchased 4.4M shares for $91.6M under its $500M program, with $400.9M remaining. The prior $500M program was completed in FY2026.
-
Securities Lawsuit Settled
The $31M class action settlement received final court approval in June 2026, removing a major legal overhang. Derivative lawsuits remain pending.
Analysis · DOCS · Technology
Net income fell 54% year-over-year to $24.3 million despite a 7% revenue gain, as heavy AI investment pushed operating expenses up 31%. Gross margin compressed four points to 85%. The company deployed $91.6 million on buybacks, leaving $400.9 million under its current authorization. A major legal overhang was removed when the securities class action settled for $31 million, while the OpenEvidence case is now in mediation. The new CFO officially took over in June. The quarter shows a profitable platform absorbing significant AI investment, but margin compression and an elevated tax rate are headwinds to watch.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DOCS was trading at $21.77 on NYSE in the Technology sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $17.15 to $76.51. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.